PharmX Technologies Limited (ASX:PHX)
Australia · Delayed Price · Currency is AUD 0.1000
-0.0100 (-9.09%)
At close: Aug 1, 2025, 4:00 PM AEST
Revance Therapeutics Market Cap
PharmX Technologies has a market cap or net worth of 59.85 million as of August 1, 2025. Its market cap has increased by 203.03% in one year.
Market Cap
59.85M
Enterprise Value
55.56M
Revenue
8.63M
Ranking
n/a
PE Ratio
507.21
Stock Price
$0.10
Market Cap Chart
Since March 16, 1998, PharmX Technologies's market cap has increased from 21.78M to 59.85M, an increase of 174.75%. That is a compound annual growth rate of 3.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 59.85M | 35.14% |
| Dec 31, 2024 | 44.29M | 80.49% |
| Dec 28, 2023 | 24.54M | 32.51% |
| Dec 28, 2022 | 18.52M | -49.95% |
| Dec 31, 2021 | 37.00M | -32.61% |
| Dec 29, 2020 | 54.90M | 68.37% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 13, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 127.86B |
| Pro Medicus | 32.80B |
| Cochlear | 20.43B |
| Sonic Healthcare | 13.51B |
| Ramsay Health Care | 8.74B |
| Telix Pharmaceuticals | 6.82B |
| Ansell | 4.35B |
| Mesoblast | 3.01B |